← Back to Clinical Trials
Recruiting NCT06735924

Influence of Metabolic Syndrome on Endogenous Oxalate Synthesis

Trial Parameters

Condition MASLD
Sponsor University of Alabama at Birmingham
Study Type INTERVENTIONAL
Phase N/A
Enrollment 28
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2023-04-26
Completion 2026-12-31
Interventions
Low-oxalate fixed diet

Brief Summary

This study aims to determine the daily rate of endogenous synthesis of oxalate using fasted urine collection and a low-oxalate controlled diet in patients with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD).

Eligibility Criteria

Inclusion Criteria: * age \>18 years * History of MASLD, with liver fat content \> 5% * Normal kidney function * Stable medication for at least 1 month for diabetes mellitus if any * Willingess to ingest fixed diets and stop dietary supplements for the study and come to UAB for visits Exclusion Criteria: * Age \< 18 years * Inaccurate 24-hour urine collections * Liver fat content \<5% * Liver cirrhosis * Evidence of other chronic liver disease, viral hepatitis * history of alcoholism within 2 years of enrollment * Contra-indication to Magnetic Resonance Imaging * Chronic kidney disease with estimated Glomerular Filtration rate \< 60 ml/min/1.73m2 * Type 1 Diabetes Mellitus or treatment with insulin * Uncontrolled diabetes * Pregnancy, lactation or intention to be * Uncontrolled hypertension * Use of weight loss medication, SGLT2 inhibitors, GLP-1 receptor agonists, osteoporosis medication, chronic NSAID * History of gastric or intestinal surgery or resection that could potentially alte

Related Trials